BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 14, 2007
View Archived Issues
Zevalin meets primary endpoint in follicular non-Hodgkin's lymphoma trial
Read More
Plasmid-mediated delivery of IGF-1 gene useful in mouse model of ALS
Read More
GSK and Oncomed form strategic alliance to develop cancer stem cell antibodies
Read More
Weight loss seen with taranabant in obese subjects
Read More
KW-2449 safe and well tolerated in phase I study in hematologic malignancies
Read More
Platelet counts, safety assessed in phase I trial of LGD-4665 in healthy males
Read More
Responses seen in immune thrombocytopenic purpura patients given R-788
Read More
Genesis Bioventures changes name to Abviva
Read More
Reckitt Benckiser acquires Adams Respiratory for approximately USD 2.3 billion
Read More
Recent patents disclose novel agents for obesity and disorders of lipoprotein metabolism
Read More
Gene Logic will be renamed Ore Pharmaceuticals
Read More
Bristol-Myers and Gilead enter agreement to commercialize Atripla in Europe
Read More
TorreyPines Therapeutics reports positive results from phase I clinical trial of NGX-426
Read More
Novel immunosuppressant agents disclosed in recent Actelion patent
Read More
Novel therapeutic agents for glaucoma reported in recent Allergan patents
Read More
UCB reports positive results from phase III trial of Vimpat for diabetic neuropathic pain
Read More
Panacos reports positive results from 350 mg cohort of phase IIb study of bevirimat
Read More
Avax reports positive results from phase I/II study of MVax for stage 3 and 4 melanoma
Read More
SIRT1 activators show therapeutic potential in animal models of type 2 diabetes
Read More
Orexigen initiates phase III trial of Contrave for obesity
Read More
Data Safety Monitoring Board recommends continuation of MAESTRO-03 trial of MBP-8298
Read More
Roche files IND application with FDA for Genmab antibody for asthma
Read More
FDA accepts EntreMed's IND application for Panzem for rheumatoid arthritis
Read More
Vivus initiates EQUATE phase III trial of Qnexa in obese patients with co-morbidities
Read More
FDA accepts for filing two sNDA for Neupro for restless legs syndrome and PD
Read More
FDA deems Neurocrine's NDA for indiplon approvable pending additional safety and efficacy data
Read More
FDA approves BioMarin therapy for PKU
Read More